Timothy Hoerz

Timothy Hoerz serves as a key procurement professional within the Department of Defense, driving the acquisition of mission-critical defense technologies aligned with national security priorities. Though his formal title is not specified, his procurement activities center on advanced technical systems, particularly in the domain of in-vitro diagnostic substance manufacturing—a niche yet strategically vital area supporting biological threat detection, medical readiness, and force health protection. He facilitates contracts that enable rapid deployment of laboratory-grade diagnostic capabilities for deployed forces, ensuring operational resilience through cutting-edge biomedical instrumentation and analytical reagents. Hoerz maintains consistent working relationships with prime defense contractors including Lockheed Martin Corporation, Huntington Ingalls Inc., The Boeing Company, Electric Boat Corporation, and Humana Government Business Inc. These partnerships reflect a reliance on large, vertically integrated systems integrators capable of delivering complex, high-assurance biomedical and engineering solutions under stringent defense standards. His contracting patterns indicate a preference for full-and-open competition, with no set-asides applied to his portfolio, suggesting a focus on technical capability, scale, and rapid delivery over socioeconomic preferences. His procurement strategy is narrowly concentrated in NAICS 325413, indicating deep specialization in the development and procurement of in-vitro diagnostic substances—such as reagents, biosensors, and assay kits—used in field-deployable medical testing platforms. This specialization underscores expertise in biotechnology procurement, regulatory compliance for defense medical systems, and the integration of diagnostic tools into military health infrastructure. His work directly supports the DoD’s mission to modernize combat health systems and enhance force readiness through advanced medical diagnostics.